Asahi Kasei

Zoll agrees $538m deal to buy sleep apnoea specialist Itamar

Itamar Medical was on the acquisition trail itself earlier this year, buying Spry Health to extend its sleep sensor technology range. Now, it’s being snapped up Zoll Medical in a deal valued at around $538 million. Israel-headquartered Itamar markets a sensing device called WatchPAT that attaches to the finger during sleep, measuring vital signs like …

Zoll agrees $538m deal to buy sleep apnoea specialist Itamar Read More »

Lilly adds to pain pipeline with Asahi Kasei licensing deal

US drugmaker Eli Lilly – still waiting for an FDA decision on one non-opioid pain drug – has just added another to its pipeline via a licensing agreement with Japan’s Asahi Kasei worth up to $410 million. Lilly is paying $20 million upfront for exclusive rights to AK1780, a P2X7 receptor antagonist in early-stage clinical …

Lilly adds to pain pipeline with Asahi Kasei licensing deal Read More »

Lilly adds to pain pipeline with Asahi Kasei licensing deal

US drugmaker Eli Lilly – still waiting for an FDA decision on one non-opioid pain drug – has just added another to its pipeline via a licensing agreement with Japan’s Asahi Kasei worth up to $410 million. Lilly is paying $20 million upfront for exclusive rights to AK1780, a P2X7 receptor antagonist in early-stage clinical …

Lilly adds to pain pipeline with Asahi Kasei licensing deal Read More »